{
  "DOI": "10.1007/s10689-020-00188-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00188-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eFamily history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We evaluated the proactive assessment of familial breast cancer (FBC) risk in primary care. Eligible women (30 to 60 years) were recruited from eight English general practices. Practices were trained on FBC risk assessment. In four randomly-assigned practices, women were invited to complete a validated, postal family history questionnaire, which practice staff inputted into decision support software to determine cancer risk. Those with increased risk were offered specialist referral. Usual care was observed in the other four practices. In intervention practices, 1127/7012 women (16.1%) returned family history questionnaires, comprising 1105 (98%) self-reported white ethnicity and 446 (39.6%) educated to University undergraduate or equivalent qualification, with 119 (10.6%) identified at increased breast cancer risk and offered referral. Sixty-seven (56%) women recommended referral were less than 50 years old. From 66 women attending specialists, 26 (39.4%) were confirmed to have high risk and recommended annual surveillance (40–60 years) and surgical prevention; while 30 (45.5%) were confirmed at moderate risk, with 19 offered annual surveillance (40–50 years). The remaining 10 (15.2%) managed in primary care. None were recommended chemoprevention. In usual care practices, only ten women consulted with concerns about breast cancer family history. This study demonstrated proactive risk assessment in primary care enables accurate identification of women, including many younger women, at increased risk of breast cancer. To improve generalisability across the population, more active methods of engagement need to be explored.\u003c/jats:p\u003e\u003cjats:p\u003e\u003cjats:italic\u003eTrial registration: CRUK Clinical Trials Database\u003c/jats:italic\u003e 11779.\u003c/jats:p\u003e",
  "alternative-id": [
    "188"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "1 March 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "18 May 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "11 June 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "NQ was a member of the English NICE guideline development group on “Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer” (CG 164), he has received honorarium from AMGEN for talks on Familial Hypercholesterolaemia. SW is a member of the CPRD Independent Scientific Advisory Committee at the UK MHRA, has received honorarium as an advisor to AMGEN-EU scientific advisory board for data science. JFRR has consulted for AstraZenca, Bayer, Carrick Therapeutics \u0026 Cullinan Oncology. He also has provided expert testimony for AstraZeneca. He holds shares in Oncimmune Holdings, FaHRAS Ltd and Carrick Therapeutics. The remaining authors have no conflicts to disclose."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The study was approved by East Midlands National Research Ethics Service (NRES) Committee (Reference 14/EM/0009)."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-4909-0644",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Qureshi",
      "given": "Nadeem",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Dutton",
      "given": "Brittany",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weng",
      "given": "Stephen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sheehan",
      "given": "Christina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chorley",
      "given": "Wendy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Robertson",
      "given": "John F. R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kendrick",
      "given": "Denise",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kai",
      "given": "Joe",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        6,
        11
      ]
    ],
    "date-time": "2020-06-11T03:52:54Z",
    "timestamp": 1591847574000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        6,
        10
      ]
    ],
    "date-time": "2021-06-10T23:28:24Z",
    "timestamp": 1623367704000
  },
  "funder": [
    {
      "DOI": "10.13039/501100013374",
      "award": [
        "206"
      ],
      "doi-asserted-by": "publisher",
      "name": "NIHR School for Primary Care Research"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        22
      ]
    ],
    "date-time": "2024-01-22T23:44:24Z",
    "timestamp": 1705967064777
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2020,
        6,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            6,
            11
          ]
        ],
        "date-time": "2020-06-11T00:00:00Z",
        "timestamp": 1591833600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            6,
            11
          ]
        ],
        "date-time": "2020-06-11T00:00:00Z",
        "timestamp": 1591833600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00188-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-020-00188-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00188-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "13-21",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        6,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        6,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(16)31392-7",
      "author": "O Ginsburg",
      "doi-asserted-by": "publisher",
      "first-page": "847",
      "journal-title": "Lancet",
      "key": "188_CR1",
      "unstructured": "Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman N, Krishnan S, Sullivan R, Kombe D, Blas MM, Parham G, Kassami N, Conteh L (2017) The global burden of women’s cancers: a grand challenge in global health. Lancet 10071:847–860. https://doi.org/10.1016/S0140-6736(16)31392-7",
      "volume": "10071",
      "year": "2017"
    },
    {
      "key": "188_CR2",
      "unstructured": "Breast Cancer Statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk. Accessed 1 May 2020"
    },
    {
      "key": "188_CR3",
      "unstructured": "Breast Cancer Survival. https://www.cancerresearchuk.org/about-cancer/breast-cancer/survival. Accessed 1 May 2020"
    },
    {
      "DOI": "10.1016/s0140-6736(02)08020-0",
      "author": "L Nystrom",
      "doi-asserted-by": "publisher",
      "first-page": "909",
      "journal-title": "Lancet",
      "key": "188_CR4",
      "unstructured": "Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 9310:909–919. https://doi.org/10.1016/s0140-6736(02)08020-0",
      "volume": "9310",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(12)61611-0",
      "author": "Independent UK Panel on Breast Cancer Screening",
      "doi-asserted-by": "publisher",
      "first-page": "1778",
      "journal-title": "Lancet",
      "key": "188_CR5",
      "unstructured": "Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 9855:1778–1786. https://doi.org/10.1016/S0140-6736(12)61611-0",
      "volume": "9855",
      "year": "2012"
    },
    {
      "DOI": "10.1093/annonc/mdj007",
      "author": "LM Woods",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "Ann Oncol",
      "key": "188_CR6",
      "unstructured": "Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 1:5–19. https://doi.org/10.1093/annonc/mdj007",
      "volume": "1",
      "year": "2006"
    },
    {
      "DOI": "10.1080/02841860802056594",
      "author": "P Christiansen",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Acta Oncol",
      "key": "188_CR7",
      "unstructured": "Christiansen P, Al-Suliman N, Bjerre K, Moller S (2008) Recurrence pattern and prognosis in low-risk breast cancer patients–data from the DBCG 89—a programme. Acta Oncol 4:691–703. https://doi.org/10.1080/02841860802056594",
      "volume": "4",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.amjsurg.2009.06.010",
      "author": "S Samphao",
      "doi-asserted-by": "publisher",
      "first-page": "538",
      "journal-title": "Am J Surg",
      "key": "188_CR8",
      "unstructured": "Samphao S, Wheeler AJ, Rafferty E, Michaelson JS, Specht MC, Gadd MA, Hughes KS, Smith BL (2009) Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg 4:538–543. https://doi.org/10.1016/j.amjsurg.2009.06.010",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1038/bjc.2011.120",
      "author": "K Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "1384",
      "journal-title": "Br J Cancer",
      "key": "188_CR9",
      "unstructured": "Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 9:1384–1392. https://doi.org/10.1038/bjc.2011.120",
      "volume": "9",
      "year": "2011"
    },
    {
      "DOI": "10.1186/bcr448",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Breast Cancer Res",
      "key": "188_CR10",
      "unstructured": "Easton DF (2002) Familial risks of breast cancer. Breast Cancer Res 5:179. https://doi.org/10.1186/bcr448",
      "volume": "5",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1399-0004.2012.01859.x",
      "author": "F Lalloo",
      "doi-asserted-by": "publisher",
      "first-page": "105",
      "journal-title": "Clin Genet",
      "key": "188_CR11",
      "unstructured": "Lalloo F, Evans DG (2012) Familial breast cancer. Clin Genet 2:105–114. https://doi.org/10.1111/j.1399-0004.2012.01859.x",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6600008",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Br J Cancer",
      "key": "188_CR12",
      "unstructured": "Antoniou AC, Pharoah PDP, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 1:76–83. https://doi.org/10.1038/sj.bjc.6600008",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1097/GIM.0b013e3182241d88",
      "author": "WS Rubinstein",
      "doi-asserted-by": "publisher",
      "first-page": "956",
      "journal-title": "Genet Med",
      "key": "188_CR13",
      "unstructured": "Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT, Wang C, Beaumont JL, Rothrock N (2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med 11:956–965. https://doi.org/10.1097/GIM.0b013e3182241d88",
      "volume": "11",
      "year": "2011"
    },
    {
      "key": "188_CR14",
      "unstructured": "NICE (2019) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (NICE Guideline CG164). https://www.nice.org.uk/guidance/cg164/chapter/Putting-this-guideline-into-practice. Accessed 1 May 2020"
    },
    {
      "author": "PW Yoon",
      "first-page": "A33",
      "issue": "1",
      "journal-title": "Prev Chronic Dis",
      "key": "188_CR15",
      "unstructured": "Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ (2009) Developing family healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6(1):A33",
      "volume": "6",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1940-6207.capr-14-0037",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "993",
      "journal-title": "Cancer Prev Res",
      "key": "188_CR16",
      "unstructured": "Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A (2014) Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res 10:993–1001. https://doi.org/10.1158/1940-6207.capr-14-0037",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ejca.2012.10.004",
      "author": "F Cardoso",
      "doi-asserted-by": "publisher",
      "first-page": "3355",
      "journal-title": "Eur J Cancer",
      "key": "188_CR17",
      "unstructured": "Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L, Gentilini O, Peccatori F, Fourquet A, Delaloge S, Marotti L, Penault-Llorca F, Kotti-Kitromilidou AM, Rodger A, Harbeck N (2012) The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 18:3355–3377. https://doi.org/10.1016/j.ejca.2012.10.004",
      "volume": "18",
      "year": "2012"
    },
    {
      "key": "188_CR18",
      "unstructured": "Zonderland HM, Tuut MK, den Heeten GJ, Asperen CJ, de Bock GH, Rutqers EJ, Westenend PJ, Smit GM, Benraadt J (2008) Eur J Cancer 152:2336–2339"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "publisher",
      "first-page": "1633",
      "journal-title": "Natl Cancer Inst",
      "key": "188_CR19",
      "unstructured": "Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Natl Cancer Inst 21:1633–1637. https://doi.org/10.1093/jnci/93.21.1633",
      "volume": "21",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.2008.062232",
      "author": "DGR Evans",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "journal-title": "J Med Genet",
      "key": "188_CR20",
      "unstructured": "Evans DGR, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HFA, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A (2009) Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet 46:254–258. https://doi.org/10.1136/jmg.2008.062232",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa031759",
      "author": "M Kriege",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "journal-title": "N Engl J Med",
      "key": "188_CR21",
      "unstructured": "Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 5:427–437",
      "volume": "5",
      "year": "2004"
    },
    {
      "author": "FH01",
      "first-page": "1127",
      "journal-title": "Lancet Oncol",
      "key": "188_CR22",
      "unstructured": "FH01 (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 12:1127–1134",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-013-9661-8",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Fam Cancer",
      "key": "188_CR23",
      "unstructured": "Evans DG, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering DM, Moss S, Wallis MG, Eccles DM, Duffy S (2014) Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02). Fam Cancer 1:13–21. https://doi.org/10.1007/s10689-013-9661-8",
      "volume": "1",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1470-2045(14)71171-4",
      "author": "J Cuzick",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "Lancet Oncol",
      "key": "188_CR24",
      "unstructured": "Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, Forbes JF, Investigators I-I (2015) Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 1:67–75. https://doi.org/10.1016/S1470-2045(14)71171-4",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1016/s0140-6736(13)62292-8",
      "author": "J Cuzick",
      "doi-asserted-by": "publisher",
      "first-page": "1041",
      "journal-title": "Lancet",
      "key": "188_CR25",
      "unstructured": "Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 9922:1041–1048. https://doi.org/10.1016/s0140-6736(13)62292-8",
      "volume": "9922",
      "year": "2014"
    },
    {
      "DOI": "10.7326/m19-2125",
      "author": "HJ Schunemann",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "journal-title": "Ann Intern Med",
      "key": "188_CR26",
      "unstructured": "Schunemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nystrom L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Grawingholt A, Saz-Parkinson Z (2019) Breast cancer screening and diagnosis: a synopsis of the european breast guidelines. Ann Intern Med 172:46–56. https://doi.org/10.7326/m19-2125",
      "volume": "172",
      "year": "2019"
    },
    {
      "key": "188_CR27",
      "unstructured": "Comprehensive Cancer Centre Netherlands (IKNL) (2012) Breast cancer dutch guidelines v2. https://www.oncoline.nl/uploaded/docs/mammacarcinoom/Dutch%20Breast%20Cancer%20Guideline%202012.pdf. Accessed 1 May 2020"
    },
    {
      "DOI": "10.1016/S0140-6736(98)07516-3",
      "author": "F Eisinger",
      "doi-asserted-by": "publisher",
      "first-page": "919",
      "journal-title": "Lancet",
      "key": "188_CR28",
      "unstructured": "Eisinger F, Geller G, Burke W, Holtzman NA (1999) Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 9156:919–920. https://doi.org/10.1016/S0140-6736(98)07516-3",
      "volume": "9156",
      "year": "1999"
    },
    {
      "DOI": "10.3399/bjgp14X676267",
      "author": "N Qureshi",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "issue": "618",
      "journal-title": "Br J Gen Pract.",
      "key": "188_CR29",
      "unstructured": "Qureshi N, O’Flynn N, Evans G (2014) Dealing with family history of breast cancer: something new, something old. Br J Gen Pract. 64(618):6–7",
      "volume": "64",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s12687-013-0173-x",
      "author": "I Nippert",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "J Community Genet",
      "key": "188_CR30",
      "unstructured": "Nippert I, Julian-Reynier C, Harris H, Evans G, van Asperen CJ, Tibben A, Schmidtke J (2014) Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet 1:69–79. https://doi.org/10.1007/s12687-013-0173-x",
      "volume": "1",
      "year": "2014"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181b2e5eb",
      "author": "JO Culver",
      "doi-asserted-by": "publisher",
      "first-page": "735",
      "journal-title": "Genet Med",
      "key": "188_CR31",
      "unstructured": "Culver JO, Bowen DJ, Reynolds SE, Pinsky LE, Press N, Burke W (2009) Breast cancer risk communication: assessment of primary care physicians by standardized patients. Genet Med 10:735–741. https://doi.org/10.1097/GIM.0b013e3181b2e5eb",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1111/ecc.12526",
      "author": "A Sollie",
      "doi-asserted-by": "publisher",
      "first-page": "1005",
      "journal-title": "Eur J Cancer Care",
      "key": "188_CR32",
      "unstructured": "Sollie A, Helsper CW, Ader RJ, Ausems MG, van der Wouden JC, Numans ME (2016) Primary care management of women with breast cancer-related concerns-a dynamic cohort study using a network database. Eur J Cancer Care 6:1005–1014. https://doi.org/10.1111/ecc.12526",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1038/sj.bjc.6603897",
      "author": "J Emery",
      "doi-asserted-by": "publisher",
      "first-page": "486",
      "journal-title": "Br J Cancer",
      "key": "188_CR33",
      "unstructured": "Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL (2007) The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 4:486–493. https://doi.org/10.1038/sj.bjc.6603897",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.4236/abcr.2014.32004",
      "author": "A Gorman",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "journal-title": "Adv Breast Cancer Res",
      "key": "188_CR34",
      "unstructured": "Gorman A, Sugrue M, Ahmed Z, Johnston A (2014) An evaluation of FaHRAS computer programmes¡¯ utility in family history triage of breast cancer. Adv Breast Cancer Res 3:17–21. https://doi.org/10.4236/abcr.2014.32004",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1093/fampra/cmi073",
      "author": "N Qureshi",
      "doi-asserted-by": "publisher",
      "first-page": "663",
      "journal-title": "Fam Pract",
      "key": "188_CR35",
      "unstructured": "Qureshi N, Bethea J, Modell B, Brennan P, Papageorgiou A, Raeburn S, Hapgood R, Modell M (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 6:663–669",
      "volume": "6",
      "year": "2005"
    },
    {
      "key": "188_CR36",
      "unstructured": "Smith T NM, Noble S (2015) The English indices of deprivation. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/464485/English_Indices_of_Deprivation_2015_-_Technical-Report.pdf. Accessed 1 May 2020"
    },
    {
      "key": "188_CR37",
      "unstructured": "FaHRAS (2019) FaHRAS primary care for GPs. https://www.fahras.co.uk/fahras-primary-care-for-gps/. Accessed 1 May 2020"
    },
    {
      "DOI": "10.1038/gim.2013.75",
      "author": "MT Scheuner",
      "doi-asserted-by": "publisher",
      "first-page": "60",
      "journal-title": "Genet Med",
      "key": "188_CR38",
      "unstructured": "Scheuner MT, Hamilton AB, Peredo J, Sale TJ, Austin C, Gilman SC, Bowen MS, Goldzweig CL, Lee M, Mittman BS, Yano EM (2014) A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet Med 1:60–69. https://doi.org/10.1038/gim.2013.75",
      "volume": "1",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ejca.2017.03.014",
      "author": "A van Erkelens",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Eur J Cancer",
      "key": "188_CR39",
      "unstructured": "van Erkelens A, Sie AS, Manders P, Visser A, Duijm LE, Mann RM, ten Voorde M, Kroeze H, Prins JB, Hoogerbrugge N (2017) Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress. Eur J Cancer 78:45–52. https://doi.org/10.1016/j.ejca.2017.03.014",
      "volume": "78",
      "year": "2017"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181f30e9e",
      "author": "MT Scheuner",
      "doi-asserted-by": "publisher",
      "first-page": "726",
      "journal-title": "Genet Med",
      "key": "188_CR40",
      "unstructured": "Scheuner MT, McNeel TS, Freedman AN (2010) Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med 11:726–735. https://doi.org/10.1097/GIM.0b013e3181f30e9e",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41416-018-0065-2",
      "author": "HJ Curtis",
      "doi-asserted-by": "publisher",
      "first-page": "1268",
      "journal-title": "Br J Cancer",
      "key": "188_CR41",
      "unstructured": "Curtis HJ, Walker AJ, Goldacre B (2018) Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis. Br J Cancer 9:1268–1275. https://doi.org/10.1038/s41416-018-0065-2",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.17226/25277",
      "doi-asserted-by": "publisher",
      "key": "188_CR42",
      "unstructured": "National Academies of Sciences, Engineering, and Medicine (2018) Understanding disparities in access to genomic medicine. In: Proceedings of a workshop. https://doi.org/10.17226/25277."
    },
    {
      "DOI": "10.1177/0969141319887405",
      "author": "VG Woof",
      "doi-asserted-by": "publisher",
      "journal-title": "J Med Screen",
      "key": "188_CR43",
      "unstructured": "Woof VG, Ruane H, Ulph F, French DP, Qureshi N, Khan N, Evans DG, Donnelly LS (2019) Engagement barriers and service inequities in the NHS Breast Screening Programme: views from British-Pakistani women. J Med Screen. https://doi.org/10.1177/0969141319887405",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s12687-019-00419-6",
      "author": "SI Lee",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "J Community Genet",
      "key": "188_CR44",
      "unstructured": "Lee SI, Patel M, Dutton B, Weng S, Luveta J, Qureshi N (2020) Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review. J Community Genet 1:73–83. https://doi.org/10.1007/s12687-019-00419-6",
      "volume": "1",
      "year": "2020"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-020-00188-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Improving primary care identification of familial breast cancer risk using proactive invitation and decision support"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "20"
}